Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 207 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

207 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 207 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

207 programs

Clinical programs

Page 1 of 5

  1. 0.3% ropivacaine and 50 μg dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Free Flap Reconstruction

    approved small molecule active

    1 trial

  2. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial

  3. 2018ZX10721202001002001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  4. 2025101109

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Allergic Rhinitis

    approved small molecule active

    1 trial

  5. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  6. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial

  7. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial

  8. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  9. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

  10. 80% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxygenation Index

    approved small molecule active

    1 trial

  11. ACEI / ARB+finerenone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Henoch Schönlein Purpura Nephritis

    approved small molecule active

    1 trial

  12. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial

  13. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  14. Alendronate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteogenesis Imperfecta

    approved small molecule completed

    1 trial

  15. Anerning particle

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Community-acquired Pneumonia

    approved small molecule active

    1 trial

  16. Anshen Buxin Liuwei Pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiac Neurosis

    approved small molecule active

    1 trial

  17. Anti-Platelet Drugs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    3 trials

  18. Aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  19. Aspirin + Clopidogrel + Rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule active

    1 trial

  20. Atomoxetine 80mg combined with oxybutynin 5mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obstructive Sleep Apnea of Adult

    approved small molecule completed

    1 trial

  21. Berberine plus lifestyle intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    approved small molecule completed

    1 trial

  22. Bisoprolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial

  23. Bortezomib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Waldenström Macroglobulinemia

    approved small molecule completed

    1 trial

  24. Brivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Herpes Zoster

    approved small molecule active

    1 trial

  25. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved other active

    1 trial

  26. Budesonide-Surfactant

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Infants

    approved small molecule terminated

    1 trial

  27. CAPA001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  28. COVAX

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    1 trial

  29. Camrelizumab + chemotherapy+Thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule active

    1 trial

  30. Chinese Herb Huang-Chi-Wu-Wu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracranial Arterial Stenosis

    approved small molecule active

    1 trial

  31. Chloroprocaine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    approved small molecule completed

    1 trial

  32. Cinacalcet HCl

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperparathyroidism; Secondary, Renal

    approved small molecule completed

    1 trial

  33. Citrate anticoagulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  34. Clopidogrel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  35. Colchicine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    In-stent Restenosis

    approved small molecule active

    1 trial

  36. Colla corii asini

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thalassemia

    approved small molecule active

    1 trial

  37. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  38. Conventional therapy + S (+)-Ketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    S-ketamine

    approved small molecule active

    1 trial

  39. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials

  40. Cytokine-induced killer cells+ FOLFOX4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved small molecule completed

    1 trial

  41. Danlou Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  42. Daratumumab and corticosteroid treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Hemophilia

    approved small molecule active

    1 trial

  43. De-escalated Dual Antiplatelet Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  44. Dexamethasone and N-acetylcysteine (NAC)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  45. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lower Limb Fracture

    approved small molecule completed

    1 trial

  46. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Post-Surgical Pain

    approved small molecule active

    1 trial

  47. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thoracic Paravertebral Blocks

    approved small molecule terminated

    1 trial

  48. Dexmedetomidine Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

207 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.